DCLK1 and renal cell carcinoma: In order to assess the effect of DCLK1-IN-1 on immune checkpoint in RCC cells, we performed Western blot to detect PD-L1 protein expression and found significant downregulation in the ACHN, 786-O, and CAKI-1 cell lines following DCLK1-IN-1 treatment (Figure 4A).